BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 936286)

  • 1. Suppression of cell-mediated cytotoxicity by lymphocytes from tumor-bearing animals.
    Hellström I; Hellström KE; Kall MA; Nelson K; Pollack S
    Transplant Proc; 1976 Jun; 8(2):255-64. PubMed ID: 936286
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular and humoral immune interactions during neoplastic development.
    Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
    Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte mediated cytotoxicity to tumor antigens.
    Hellström I; Hellström KE
    Johns Hopkins Med J Suppl; 1974; 3():37-50. PubMed ID: 4608238
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preferential efficicacy of immunocomplexes in the facilitation of tumor allografts].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1973 Nov; 124(4):567-72. PubMed ID: 4134880
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxicity in vitro by products of specifically stimulated spleen cells: susceptibility of tumor cells and normal cells.
    Meltzer MS; Bartlett GL
    J Natl Cancer Inst; 1972 Nov; 49(5):1439-43. PubMed ID: 4568090
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunostimulation of the growth of a syngeneic sarcoma primarily induced in mice by simian adenovirus SA7(C8)].
    Ageenko AI; Erkhov VS
    Vopr Onkol; 1977; 23(8):57-60. PubMed ID: 906408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic aspects of cancer.
    Sophocles AM; Nadler SH
    Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
    [No Abstract]   [Full Text] [Related]  

  • 9. [Disturbance of immune surveillance in tumor-bearing host (author's transl)].
    Haba S; Kitagawa M
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(10):930-8. PubMed ID: 4612620
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Proposed mechanisms by which autochthonous neoplasms escape immune rejection.
    Coggin JH; Ambrose KR; Dierlam PJ; Anderson NG
    Cancer Res; 1974 Aug; 34(8):2092-101. PubMed ID: 4366506
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antigenic reactivation in vitro of the cytotoxic activity of lymphoid cells from mice bearing syngeneic tumors].
    Schaaf-Lafontaine N
    C R Seances Soc Biol Fil; 1977; 171(3):663-6. PubMed ID: 144008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement phenomenon.
    Petrányi GG
    Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):800-6. PubMed ID: 1254955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor antigens and tumor-host relationships.
    Baldwin RW; Price MR
    Annu Rev Med; 1976; 27():151-63. PubMed ID: 779594
    [No Abstract]   [Full Text] [Related]  

  • 18. The activity of regional nodes in the evolution of immune responses to allogeneic and isogeneic tumors.
    Barna B; Deodhar SD
    Cancer Res; 1975 Apr; 35(4):920-6. PubMed ID: 1116149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 20. Humoral factors influencing cell-mediated immune responses to tumour-associated antigens.
    Baldwin RW; Embleton MJ; Robins RA
    Proc R Soc Med; 1973 May; 66(5):466-8. PubMed ID: 4351926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.